Literature DB >> 7919765

Increasing incidence of ventricular septal defects caused by improved detection rate.

A Meberg1, J E Otterstad, G Frøland, S Sørland, S Nitter-Hauge.   

Abstract

In a population-based study in children born alive during the 10-year period from 1982 to 1991 (n = 22,810), ventricular septal defects (VSDs) were diagnosed in 127 cases, an incidence of 5.6 per 1000. The incidence was significantly higher in the cohort of children born during the 6-year period from 1986 to 1991 than among those born in the preceding 4-year period, 1982-1985 (6.5 and 4.0 per 1000 respectively; p < 0.05). The increase was caused entirely by an increased detection rate of small defects in the muscular part of the interventricular septum after introducing echocardiography as a standard method for investigating suspect congenital heart defects in the neonatal period. This also explained entirely an increase in the total incidence of congenital heart defects to 10.6 per 1000 in the last period from 8.4 per 1000 in the first, although this increase was not significant (p > 0.05). More children born in 1986-1991 had spontaneous closure of their VSDs (75.5%) than those born in 1982-1985 (51.5%) (p < 0.05). In 69.3% of patients the VSDs closed during the first year of life. For the cohort born in 1986-1991, 84.6% of the defects located in the muscular part of the septum closed spontaneously. Small defects in the muscular part of the interventricular septum with spontaneous closure in early life may represent the tail of a normal developmental process, and not defects in the sense of malformations.

Entities:  

Mesh:

Year:  1994        PMID: 7919765     DOI: 10.1111/j.1651-2227.1994.tb13102.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women.

Authors:  Alessandro Sacco; Claudio Coco; Lucia Mangiafico; Pietro Cignini; Alessandra Tiezzi; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2007-10

2.  Preoperative evaluation and surgery in isolated ventricular septal defects: a 21 year perspective.

Authors:  A Nygren; J Sunnegårdh; H Berggren
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

3.  Incidence and risk factors for ventricular septal defect in "low risk" neonates.

Authors:  A J Sands; F A Casey; B G Craig; J C Dornan; J Rogers; H C Mulholland
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-07       Impact factor: 5.747

4.  The natural history of ventricular septal defects.

Authors:  S W Turner; S Hunter; J P Wyllie
Journal:  Arch Dis Child       Date:  1999-11       Impact factor: 3.791

5.  Prevalence and development of additional cardiac abnormalities in 1448 patients with congenital ventricular septal defects.

Authors:  S Glen; J Burns; P Bloomfield
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

6.  Prenatal ultrasonography and Doppler sonography for the clinical investigation of isolated ventricular septal defects in a late second-trimester population.

Authors:  Wei-Hsiu Chiu; Ming-Chon Hsiung; Ran-Chou Chen; Xiao-Min Xiao; Cai-Lin Wu; Tao-Hsin Tung
Journal:  Eur J Med Res       Date:  2014-01-24       Impact factor: 2.175

7.  Prenatal detection of cardiac anomalies in fetuses with single umbilical artery: diagnostic accuracy comparison of maternal-fetal-medicine and pediatric cardiologist.

Authors:  Ilir Tasha; Rachel Brook; Heidi Frasure; Noam Lazebnik
Journal:  J Pregnancy       Date:  2014-03-02

8.  Subspecialty surveillance of long-term course of small and moderate muscular ventricular septal defect: heterogenous practices, low yield.

Authors:  Erik L Frandsen; Aswathy V House; Yunbin Xiao; David A Danford; Shelby Kutty
Journal:  BMC Pediatr       Date:  2014-11-04       Impact factor: 2.125

9.  Congenital heart disease in the Niger Delta region of Nigeria: a four-year prospective echocardiographic analysis.

Authors:  B E Otaigbe; P N Tabansi
Journal:  Cardiovasc J Afr       Date:  2014-11-10       Impact factor: 1.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.